Published in Biochemistry (Mosc) on January 01, 2002
Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence. Nat Cell Biol (2006) 4.54
In stent restenosis: bane of the stent era. J Clin Pathol (2006) 1.71
Membrane associated proteases and their inhibitors in tumour angiogenesis. J Clin Pathol (2004) 1.10
Adipose-derived mesenchymal stromal cells from aged patients with coronary artery disease keep mesenchymal stromal cell properties but exhibit characteristics of aging and have impaired angiogenic potential. Stem Cells Transl Med (2013) 1.08
Biochemical insights into the role of matrix metalloproteinases in regeneration: challenges and recent developments. Future Med Chem (2009) 1.05
A competitive hexapeptide inhibitor of annexin A2 prevents hypoxia-induced angiogenic events. J Cell Sci (2011) 0.94
Disturbed angiogenic activity of adipose-derived stromal cells obtained from patients with coronary artery disease and diabetes mellitus type 2. J Transl Med (2014) 0.85
Pharmacotherapy for end-stage coronary artery disease. Expert Opin Pharmacother (2010) 0.83
PEGylated DX-1000: pharmacokinetics and antineoplastic activity of a specific plasmin inhibitor. Neoplasia (2007) 0.82
Structure and functions of classical cadherins. Biochemistry (Mosc) (2001) 1.40
Stretch affects phenotype and proliferation of vascular smooth muscle cells. Mol Cell Biochem (1995) 1.21
Morphological alterations in endothelial cells from human aorta and umbilical vein induced by forskolin and phorbol 12-myristate 13-acetate: a synergistic action of adenylate cyclase and protein kinase C activators. Proc Natl Acad Sci U S A (1986) 1.17
Guanine nucleotide-dependent, pertussis toxin-insensitive regulation of phosphoinositide turnover by bradykinin in bovine pulmonary artery endothelial cells. FASEB J (1989) 1.04
Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 3. Inhibitory effect of SkQ1 on tumor development from p53-deficient cells. Biochemistry (Mosc) (2008) 1.04
T-cadherin and signal-transducing molecules co-localize in caveolin-rich membrane domains of vascular smooth muscle cells. FEBS Lett (1998) 1.03
Urokinase as a multidomain protein and polyfunctional cell regulator. Biochemistry (Mosc) (2002) 1.01
Influence of vasoactive agents on cytoplasmic free calcium in vascular endothelial cells. J Appl Physiol (1985) (1988) 0.97
Ca2+-dependent interaction of 5-dimethylaminonaphthalene-1-sulfonyl-calmodulin with cyclic nucleotide phosphodiesterase, calcineurin, and troponin I. J Biol Chem (1982) 0.92
Density- and proliferation status-dependent expression of T-cadherin, a novel lipoprotein-binding glycoprotein: a function in negative regulation of smooth muscle cell growth? FEBS Lett (1998) 0.89
Platelet membrane calmodulin-stimulated calcium-adenosine triphosphatase. Altered activity in essential hypertension. Hypertension (1986) 0.87
Urokinase plasminogen activator enhances neointima growth and reduces lumen size in injured carotid arteries. J Hypertens (2000) 0.86
LDL binds to surface-expressed human T-cadherin in transfected HEK293 cells and influences homophilic adhesive interactions. FEBS Lett (1999) 0.86
Urokinase plasminogen activator induces human smooth muscle cell migration and proliferation via distinct receptor-dependent and proteolysis-dependent mechanisms. Mol Cell Biochem (1999) 0.86
Endothelin-1 and endothelin-3 stimulate calcium mobilization by different mechanisms in vascular smooth muscle. Biochem Biophys Res Commun (1992) 0.86
Chemotactic effect of urokinase plasminogen activator: a major role for mechanisms independent of its proteolytic or growth factor domains. J Recept Signal Transduct Res (1999) 0.86
Mesenchymal stem cells in tissue growth and repair. Acta Naturae (2011) 0.85
Ligand selectivity of 105 kDa and 130 kDa lipoprotein-binding proteins in vascular-smooth-muscle-cell membranes is unique. Biochem J (1996) 0.84
Different electrical responses to vasoactive agonists in morphologically distinct smooth muscle cell types. Circ Res (1994) 0.84
Involvement of Ni protein in the functional coupling of the atrial natriuretic factor (ANF) receptor to adenylate cyclase in rat lung plasma membranes. Eur J Biochem (1988) 0.84
Interaction of stable prostaglandin endoperoxide analogs U46619 and U44069 with human platelet membranes: coupling of receptors with high-affinity GTPase and adenylate cyclase. Thromb Res (1985) 0.83
Concerted effects of lipoproteins and angiotensin II on signal transduction processes in vascular smooth muscle cells. Arterioscler Thromb (1993) 0.83
[Mechanisms of Vascular Remodeling Following Arterial Injury]. Kardiologiia (2015) 0.83
Calmodulin activates adenylate cyclase from rabbit heart plasma membranes. FEBS Lett (1984) 0.83
Cardiovascular drugs and atherosclerosis: effects of calcium antagonists, beta-blockers, and nitrates on atherosclerotic characteristics of human aortic cells. J Cardiovasc Pharmacol (1988) 0.83
[Adipose stromal cells--plastic type of cells with high therapeutic potential]. Tsitologiia (2006) 0.81
Characteristics of low and high density lipoprotein binding and lipoprotein-induced signaling in quiescent human vascular smooth muscle cells. Mol Pharmacol (1994) 0.81
Low- and high-density lipoproteins as hormonal regulators of platelet, vascular endothelial and smooth muscle cell interactions: relevance to hypertension. J Hypertens Suppl (1991) 0.80
Heterotrimeric Gi protein is associated with the inositol 1,4,5-trisphosphate receptor complex and modulates calcium flux. Cell Calcium (1998) 0.80
Cellular signalling by lipoproteins in cultured smooth muscle cells from spontaneously hypertensive rats. J Vasc Res (1993) 0.80
Insulin resistance and adipogenesis: role of transcription and secreted factors. Biochemistry (Mosc) (2013) 0.80
Characterization of an atypical lipoprotein-binding protein in human aortic media membranes by ligand blotting. Biochem J (1994) 0.80
T-cadherin activates Rac1 and Cdc42 and changes endothelial permeability. Biochemistry (Mosc) (2009) 0.80
Increased pressure induces sustained protein kinase C-independent herbimycin A-sensitive activation of extracellular signal-related kinase 1/2 in the rabbit aorta in organ culture. Circ Res (1997) 0.80
[Role of guanyl nucleotides in regulation of activity of heart adenylate cyclase by chloride ions]. Biokhimiia (1981) 0.80
Oxidized low density lipoproteins stimulate phosphoinositide turnover in cultured vascular smooth muscle cells. Arterioscler Thromb (1992) 0.79
Urokinase induces ROS production in vascular smooth muscle cells. Bull Exp Biol Med (2006) 0.79
Regulation of Immunity via Multipotent Mesenchymal Stromal Cells. Acta Naturae (2012) 0.79
[Biochemical features of platelet alpha2-adrenergic receptors and their connection with an increase in concentration of intracellular Ca2+]. Biokhimiia (1989) 0.79
Vascular signal transduction and atherosclerosis. Ann N Y Acad Sci (1990) 0.79
Stimulation of non-selective cation channels providing Ca2+ influx into platelets by platelet-activating factor and other aggregation inducers. Eur J Biochem (1991) 0.78
Low- and high-density lipoproteins as mitogenic factors for vascular smooth muscle cells: individual, additive and synergistic effects. J Vasc Res (1995) 0.78
Calcium-dependent interaction of dansyl-calmodulin and phosphodiesterase: relationship to Ca2+ requirement for enzyme activation. Adv Cyclic Nucleotide Protein Phosphorylation Res (1984) 0.78
[T-cadherin suppresses the cell proliferation of mouse melanoma B16F10 and tumor angiogenesis in the model of the chorioallantoic membrane]. Ontogenez (2010) 0.78
Activation energy of skeletal muscle sarcolemmal Na+,K+-adenosine triphosphatase. Biochim Biophys Acta (1974) 0.78
[Adipose tissue stromal cells -- multipotent cells with therapeutic potential for stimulation of angiogenesis in tissue ischemia]. Kardiologiia (2006) 0.78
Epinephrine potentiates activation of human platelets by low density lipoproteins. Biochim Biophys Acta (1991) 0.77
[Therapeutic Angiogenesis Using Growth Factors: Current State and Prospects for Development]. Kardiologiia (2015) 0.77
Monocyte integrin expression and monocyte-platelet complex formation in humans with coronary restenosis. Clin Exp Pharmacol Physiol (2001) 0.77
[Effect of pH on Ca-binding properties of calmodulin and on its interaction with Ca-dependent phosphodiesterase of cyclic nucleotides]. Biokhimiia (1981) 0.77
Alterations in beta-adrenoceptor density on T-lymphocytes upon activation with interleukin-2 and phytohaemagglutinin. Biomed Sci (1990) 0.77
Identification of 130 kDa cell surface LDL-binding protein from smooth muscle cells as a partially processed T-cadherin precursor. Biochim Biophys Acta (1999) 0.77
Molecular modeling as a new approach to the development of urokinase inhibitors. Bull Exp Biol Med (2015) 0.77
The regulatory effect of ATP and its non-hydrolyzed analogs on heart adenylate cyclase. Biochem Int (1983) 0.77
Interaction between kringle and growth-factor-like domains in the urokinase molecule: possible role in stimulation of chemotaxis. Biochemistry (Mosc) (2008) 0.77
Abnormal cellular calcium regulation in essential hypertension. J Cardiovasc Pharmacol (1986) 0.77
[Phorbol ester blocks the coupling of GTP-binding protein with receptor-controlled calcium channels]. Biokhimiia (1989) 0.77
Blocking of the receptor-stimulated calcium entry into human platelets by verapamil and nicardipine. Thromb Res (1988) 0.77
Platelets in patients with homozygous familial hypercholesterolemia are sensitive to Ca(2+)-mobilizing activity of low density lipoproteins. Atherosclerosis (1992) 0.77
Urokinase plasminogen activator system in humans with stable coronary artery disease. Clin Exp Pharmacol Physiol (1999) 0.77
[UROKINASE SYSTEM INVOLVES IN VASCULAR CELLS MIGRATION AND REGULATES THE GROWTH AND BRANCHING OF CAPILLARIES]. Tsitologiia (2015) 0.76
[Mechanism of stimulation of angiogenesis in ischemic myocardium with the help of adipose tissue stromal cells]. Kardiologiia (2010) 0.76
LDL- and agonist-induced Ca(2+)-mobilization in platelets of healthy subjects and in patients with familial hyperlipoproteinemia type II. Thromb Res (1991) 0.76
Selective inactivation by endogenous protein kinase C of human platelet high-affinity GTPase coupled with PAF receptors. J Mol Cell Cardiol (1989) 0.76
Ca2+-agonistic effect of a T-type Ca-channel blocker mibefradil (Ro 40-5967). Membr Cell Biol (2000) 0.76
Relationship between the inhibition of receptor-induced increase in cytosolic free calcium concentration and the vasodilator effects of nitrates in patients with congestive heart failure. Int J Cardiol (1990) 0.76
Characteristics of smooth muscle cell lipoprotein binding proteins (p105/p130) as T-cadherin and regulation by positive and negative growth regulators. Biochem Biophys Res Commun (1998) 0.76
[Genetic factors of risk of ischemic heart disease development in patients with familial hypercholesterolemia]. Kardiologiia (2005) 0.76
Decrease of platelet aggregation and spreading via inhibition of the cAMP phosphodiesterase by trapidil. FEBS Lett (1984) 0.76
Calmodulin and troponin C as targets for drug action. Biomed Biochim Acta (1987) 0.76
Blockade of receptor-operated calcium channels by mibefradil (Ro 40-5967): effects on intracellular calcium and platelet aggregation. Cardiovasc Drugs Ther (1995) 0.76
Evidence for the receptor-operated calcium channels in human platelet plasma membrane. Thromb Res (1987) 0.76
Urokinase stimulates production of matrix metalloproteinase-9 in fibroblasts with involvement of reactive oxygen species. Bull Exp Biol Med (2014) 0.76
Comparison of binding of 3H-desmethoxyverapamil and 3H-mibefradil in vascular smooth muscle and heart membranes. Possible binding of mibefradil to a site distinct from the phenylalkylamine-binding site. Arzneimittelforschung (1996) 0.76
Atherogenic effects of beta blockers on cells cultured from normal and atherosclerotic aorta. Am J Cardiol (1988) 0.76
Platelet calcium-linked abnormalities in essential hypertension. Ann N Y Acad Sci (1986) 0.76
[Molecular mechanisms of gradient sensing in mesenchymal cells]. Ross Fiziol Zh Im I M Sechenova (2013) 0.75
[Hypoxia as the main activator of angiogenesis and fatty tissue growth]. Ross Fiziol Zh Im I M Sechenova (2009) 0.75
[Participation of calmodulin and the guanine nucleotide-binding regulator component in regulating cardiac adenylate cyclase]. Dokl Akad Nauk SSSR (1984) 0.75
[The molecular basis for active transport of univalent cations]. Usp Sovrem Biol (1976) 0.75
[Calcium-dependent regulation of cardiac adenyl cyclase by calmodulin]. Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR (1984) 0.75
[Fast and highly-sensitive method of quantitative determination of carnosine and anserine in animal tissues]. Vopr Med Khim (1977) 0.75
Regulation of adenylate cyclase by hormones and guanine nucleotides in normal, desensitized, and resensitized rabbit heart. Adv Myocardiol (1982) 0.75
[Economic reform is the road to increasing the efficiency of pharmacy administration]. Farm Zh (1973) 0.75
[Pathomorphosis of lung cancer following preoperative intensive split radiation]. Vrach Delo (1976) 0.75
[Effect of fatty acids on calmodulin regulation of adenylate cyclase from the brain striatal system]. Biokhimiia (1983) 0.75
The effect of alprenolol on the beta-receptor and adenylate cyclase activity in rabbit heart membranes. Mol Pharmacol (1981) 0.75
[Status and tasks of the drug control service in the Ukraine]. Farm Zh (1974) 0.75
[Lateral thoracotomy without complete muscle dissection]. Klin Khir (1976) 0.75
Guanine-nucleotide-dependent inhibition of adenylate cyclase of rabbit heart by glucagon. Eur J Biochem (1984) 0.75
[Inhibition of cyclic nucleotide phosphodiesterase from rabbit heart by hydroxypyridines]. Vopr Med Khim (1983) 0.75
[Drug supply of therapeutic institutions in the Ukraine during 1962-1972]. Sov Zdravookhr (1974) 0.75
Characterization of two forms of cyclic nucelotide phosphodiesterase from rabbit heart. Adv Myocardiol (1982) 0.75
[Interrelation of the regulatory effects of adenosine, ATP and fluoride on heart adenylate cyclase]. Biokhimiia (1982) 0.75
[Tasks of pharmacy workers of the Republic in fulfilling the socialist obligations of the 2d year of the 10th Five-Year Plan]. Farm Zh (1977) 0.75
[Effect of lipids on the binding of calmodulin with cyclic nucleotide phosphodiesterase]. Biokhimiia (1983) 0.75